The public’s views about the perceived safety of clinical trials and the motives of study volunteers have improved significantly during the past six years, and a large percentage of patients deemed ineligible to participate choose to take no action in finding another clinical trial. These are but a few of the findings of a new study of nearly 6,000 respondents worldwide conducted by the Center for Information & Study on Clinical Research Participation (CISCRP).
Strategies for finding, eliminating sites’ hidden costs
As a cottage industry, investigative sites continue to face mounting concerns about clinical trial costs which they either cannot collect or must negotiate with sponsors and CROs. These expenses can include everything from investigator meetings, IRB submissions, source documents, study preparation, site initiation and document storage, to the unexpected costs of paying staff when trials are delayed or postponed or having to wait 90 days or longer for payments from sponsors...
To read the full articles for this issue of The CenterWatch Monthly, please click here for subscription information.
